Curriculum · Infection Control
Tuberculosis contact screening and chemoprophylaxis
What it is
Contact screening asks whether a person in contact with a case of tuberculosis has been infected. Chemoprophylaxis is the drug course given to a contact in whom that infection is shown while the chest X-ray is normal.
Causes and risk
Almost all infections with M. tuberculosis are due to inhalation of droplet nuclei, 1 to 5 microns in diameter, which are infectious particles from a person with pulmonary tuberculosis aerosolized by coughing, sneezing or talking, and which dry while airborne and remain suspended for long periods. The air in a room occupied by a person with pulmonary tuberculosis may remain infectious for approximately 30 minutes even after that person has left it, and infection does not generally occur out of doors because M. tuberculosis is killed by ultraviolet light.
The most important determinants of infection of tuberculin-negative persons are closeness of contact and infectiousness of the source. Prolonged exposure and multiple aerosol inocula are usually required to establish the infection.
How it is diagnosed
The diagnosis of latent TB infection involves demonstration of immune memory to mycobacterial proteins, and two tests are available.
The Mantoux skin test consists of an intradermal injection of one-tenth of a milliliter of PPD tuberculin and represents delayed type hypersensitivity. The size of induration is measured 48 to 72 hours later; erythema should not be measured. Two ways of reading that induration are set out, and they do not use the same numbers. One reads it by the risk group of the person: 5 mm or more in close contacts of active TB cases, HIV-positive persons, an abnormal chest x-ray consistent with old healed TB, and steroid use or organ transplantation recipients; 10 mm or more in high-risk groups such as healthcare workers, prisoners and nursing home residents; and 15 mm or more in all others with no risk factors. The other reads it by BCG: a raised indurated lesion above 6 mm diameter in nonvaccinated adults, and above 15 mm in BCG-vaccinated adults.
A false negative, anergic skin test occurs with immunosuppression due to HIV infection with CD4+ below 200/mm3, sarcoidosis, drugs such as chemotherapy, anti-TNF therapy and steroids, and cross-reactivity with non-tuberculous mycobacteria and BCG vaccination. Interferon-gamma release assays overcome these limitations. They detect T-cell secretion of interferon-gamma following exposure to M tuberculosis-specific antigens, and they are highly specific compared with the skin test with similar or better sensitivity, but they do not differentiate between active and latent infection.